FUSIX
Teva Pharmaceuticals USA, Inc.
Application Filed: 2017-10-12
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87643104 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M10 |
| Employee Name | VOHRA, SANJEEV KUMAR |
Timeline
| 2017-10-12 | Application Filed |
| 2018-03-20 | Published for Opposition |
| 2018-05-15 | Location: INTENT TO USE SECTION |
| 2019-06-17 | Abandon |
| 2019-06-17 | Status: Dead/Abandoned |
| 2019-06-17 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Teva Pharmaceuticals USA, Inc. |
| Address | 1090 Horsham Road North Wales PA 19454 |
| Legal Entity Type | Corporation |
| Legal Entity State | PA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-10-16 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-10-20 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-01-22 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-01-23 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-01-23 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-01-23 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-01-30 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-01-30 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-01-30 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-02-05 | 10 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-02-28 | 11 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-03-20 | 12 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-03-20 | 13 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-05-15 | 14 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-11-12 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-11-12 | 16 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-11-12 | 17 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-14 | 18 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-06-17 | 19 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-06-17 | 20 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FUSIX 87643104 not registered Dead/Abandoned |
Teva Pharmaceuticals USA, Inc. 2017-10-12 |
 FUSIX 74250313 1769813 Dead/Cancelled |
DU PONT PIXEL SYSTEMS LIMITED 1992-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 